Results 161 to 170 of about 8,961 (261)

China’s “super microscope”: High Energy Photon Source enters joint commissioning phase

The Innovation
Zhihui Zhang
doaj   +1 more source

Pervious Concrete as a Controlled Stormwater Capture-Pretreatment Interface in a School-Scale Decentralized Harvesting System. [PDF]

Materials (Basel)
Frausto Castillo RF, Pérez Bueno JJ, Rodríguez Zamora PO, Tinoco Montañez H, Guerrero JAR, Montoya García ML, López Jiménez Á, Estrada Arteaga C, Reyes Araiza JL, Mendoza López ML, Manzano-Ramírez A.   +10 more
europepmc   +1 more source

Normal‐Appearing White Matter Injury Mediates Chronic Deep Venous Hypoxia and Disease Progression in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang, Huiying Wang, Zhizheng Zhuo, Ai Guo, Ke Lv, Decai Tian, Chao Chai, Yunyun Duan, Shuang Xia   +8 more
wiley   +1 more source

Medical Equipment Planning in Ambulatory Surgery Centers: Enhancing Efficiency, Innovation, and Patient Care. [PDF]

Cureus
Nandy B, Jha M.
europepmc   +1 more source

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

The NEXT-100 Detector. [PDF]

Eur Phys J C Part Fields
NEXT Collaboration.
europepmc   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao, Rong Li, Yu‐Xiang Jiao, Kai Ma, Hong‐Qi Yang, Zheng‐Yu Sun, Jie‐Wen Zhang, Shuai Chen   +7 more
wiley   +1 more source

Barriers, facilitators and strategies for implementing on-site hospital solar power in low- and middle-income countries: a systematic review, global prioritisation survey and development of an implementation tool. [PDF]

BMJ Glob Health
Linder C, Tellis R, Adisa A, Ghosh D, Suroy A, Singh D, Marshall N, Penney O, Haque PD, Ingabire JCA, Ramos-De La Medina A, Nepogodiev D, Bhangu A, NIHR Group on Environmentally Sustainable Hospitals.   +13 more
europepmc   +1 more source